Cargando…

The Role of Angiotensin‐Converting Enzyme Inhibitors and β‐Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients

Detalles Bibliográficos
Autores principales: Brown, Sherry‐Ann, Okwuosa, Tochi M., Barac, Ana, Volgman, Annabelle Santos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033832/
https://www.ncbi.nlm.nih.gov/pubmed/31960742
http://dx.doi.org/10.1161/JAHA.119.015327
_version_ 1783499750094405632
author Brown, Sherry‐Ann
Okwuosa, Tochi M.
Barac, Ana
Volgman, Annabelle Santos
author_facet Brown, Sherry‐Ann
Okwuosa, Tochi M.
Barac, Ana
Volgman, Annabelle Santos
author_sort Brown, Sherry‐Ann
collection PubMed
description
format Online
Article
Text
id pubmed-7033832
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70338322020-02-27 The Role of Angiotensin‐Converting Enzyme Inhibitors and β‐Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients Brown, Sherry‐Ann Okwuosa, Tochi M. Barac, Ana Volgman, Annabelle Santos J Am Heart Assoc Cardio‐Oncology Spotlight John Wiley and Sons Inc. 2020-01-21 /pmc/articles/PMC7033832/ /pubmed/31960742 http://dx.doi.org/10.1161/JAHA.119.015327 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Cardio‐Oncology Spotlight
Brown, Sherry‐Ann
Okwuosa, Tochi M.
Barac, Ana
Volgman, Annabelle Santos
The Role of Angiotensin‐Converting Enzyme Inhibitors and β‐Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients
title The Role of Angiotensin‐Converting Enzyme Inhibitors and β‐Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients
title_full The Role of Angiotensin‐Converting Enzyme Inhibitors and β‐Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients
title_fullStr The Role of Angiotensin‐Converting Enzyme Inhibitors and β‐Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients
title_full_unstemmed The Role of Angiotensin‐Converting Enzyme Inhibitors and β‐Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients
title_short The Role of Angiotensin‐Converting Enzyme Inhibitors and β‐Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients
title_sort role of angiotensin‐converting enzyme inhibitors and β‐blockers in primary prevention of cardiac dysfunction in breast cancer patients
topic Cardio‐Oncology Spotlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033832/
https://www.ncbi.nlm.nih.gov/pubmed/31960742
http://dx.doi.org/10.1161/JAHA.119.015327
work_keys_str_mv AT brownsherryann theroleofangiotensinconvertingenzymeinhibitorsandbblockersinprimarypreventionofcardiacdysfunctioninbreastcancerpatients
AT okwuosatochim theroleofangiotensinconvertingenzymeinhibitorsandbblockersinprimarypreventionofcardiacdysfunctioninbreastcancerpatients
AT baracana theroleofangiotensinconvertingenzymeinhibitorsandbblockersinprimarypreventionofcardiacdysfunctioninbreastcancerpatients
AT volgmanannabellesantos theroleofangiotensinconvertingenzymeinhibitorsandbblockersinprimarypreventionofcardiacdysfunctioninbreastcancerpatients
AT brownsherryann roleofangiotensinconvertingenzymeinhibitorsandbblockersinprimarypreventionofcardiacdysfunctioninbreastcancerpatients
AT okwuosatochim roleofangiotensinconvertingenzymeinhibitorsandbblockersinprimarypreventionofcardiacdysfunctioninbreastcancerpatients
AT baracana roleofangiotensinconvertingenzymeinhibitorsandbblockersinprimarypreventionofcardiacdysfunctioninbreastcancerpatients
AT volgmanannabellesantos roleofangiotensinconvertingenzymeinhibitorsandbblockersinprimarypreventionofcardiacdysfunctioninbreastcancerpatients